This is a Validated Antibody Database (VAD) review about mouse Tnfrsf10b, based on 6 published articles (read how Labome selects the articles), using Tnfrsf10b antibody in all methods. It is aimed to help Labome visitors find the most suited Tnfrsf10b antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Tnfrsf10b synonym: DR5; KILLER; Ly98; MK; TRAILR2; TRICK2A; TRICK2B; TRICKB

Invitrogen
hamsters monoclonal (MD5-1)
  • flow cytometry; mouse; loading ...; fig s3g
In order to investigate the use of red blood cells expressing disease-associated autoantigenas a means of inducing antigen-specific tolerance, Invitrogen Tnfrsf10b antibody (eBioscience, 12-5883-82) was used in flow cytometry on mouse samples (fig s3g). Proc Natl Acad Sci U S A (2017) ncbi
hamsters monoclonal (MD5-1)
  • flow cytometry; mouse
Invitrogen Tnfrsf10b antibody (eBioscience, MD5-1) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
hamsters monoclonal (MD5-1)
  • flow cytometry; mouse
In order to identify a role for TRAIL in apoptosis during listeriosis, Invitrogen Tnfrsf10b antibody (eBioscience, MD5-1) was used in flow cytometry on mouse samples . J Immunol (2004) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1b
Abcam Tnfrsf10b antibody (Abcam, ab8416) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1b). PLoS ONE (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:500; loading ...; fig 5g
Abcam Tnfrsf10b antibody (Abcam, ab8416) was used in western blot on human samples at 1:500 (fig 5g). Mol Cancer Res (2017) ncbi
BioLegend
hamsters monoclonal (MD5-1)
BioLegend Tnfrsf10b antibody (BioLegend, 119905) was used . Oncogenesis (2016) ncbi
Articles Reviewed
  1. Jun B, Lee W, Jang J, Jeong S, Chang Y, Lee S, et al. Relation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resection. PLoS ONE. 2020;15:e0227440 pubmed publisher
  2. Pishesha N, Bilate A, Wibowo M, Huang N, Li Z, Deshycka R, et al. Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. Proc Natl Acad Sci U S A. 2017;114:3157-3162 pubmed publisher
  3. Dimberg L, Towers C, Behbakht K, Hotz T, Kim J, Fosmire S, et al. A Genome-Wide Loss-of-Function Screen Identifies SLC26A2 as a Novel Mediator of TRAIL Resistance. Mol Cancer Res. 2017;15:382-394 pubmed publisher
  4. West A, Martin B, Andrews D, Hogg S, Banerjee A, Grigoriadis G, et al. The SMAC mimetic, LCL-161, reduces survival in aggressive MYC-driven lymphoma while promoting susceptibility to endotoxic shock. Oncogenesis. 2016;5:e216 pubmed publisher
  5. Dang V, Tanabe K, Tanaka Y, Tokumoto N, Misumi T, Saeki Y, et al. Fasting enhances TRAIL-mediated liver natural killer cell activity via HSP70 upregulation. PLoS ONE. 2014;9:e110748 pubmed publisher
  6. Zheng S, Jiang J, Shen H, Chen Y. Reduced apoptosis and ameliorated listeriosis in TRAIL-null mice. J Immunol. 2004;173:5652-8 pubmed